Announcements Trials
Browse Landscape

Status

Completed 152Recruiting 101Unknown 87Terminated 51Active not recruiting 18Not yet recruiting 17Withdrawn 12Suspended 3Enrolling by invitation 2No longer available 1

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

Other solid neoplasm 2

Conditions

Neoplasms 73Breast Neoplasms 73Colorectal Neoplasms 39Prostatic Neoplasms 37Carcinoma, Non-Small-Cell Lung 27Lung Neoplasms 26Uterine Cervical Neoplasms 20Stomach Neoplasms 20Carcinoma, Hepatocellular 20Pancreatic Neoplasms 15Anxiety Disorders 15Leukemia, Myeloid, Acute 14Hematologic Neoplasms 13Colonic Neoplasms 13Urinary Bladder Neoplasms 12Lymphoma, Follicular 12Brain Neoplasms 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Head and Neck Neoplasms 10Esophageal Neoplasms 10Diabetes Mellitus 10Sarcoma 9Ovarian Neoplasms 9Melanoma 9Liver Neoplasms 9Esophageal Squamous Cell Carcinoma 9Rectal Neoplasms 8Pulmonary Disease, Chronic Obstructive 8Epilepsy 8Disease 8

Interventions

trifluridine tipiracil drug combination 1tegafur-gimeracil-oteracil 1Tegafur 1S 1 (combination) 1Fluorouracil 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Enrolling by invitation × Solid Tumor × Clear all
NCT04762862 2025-04-10

QUANTACT

Centre Hospitalier Universitaire de Nice

Enrolling by invitation
1,200 enrolled
Other solid neoplasm

Solid Tumor

NCT04260269 2024-12-12

CardioSwitch

Helsinki University Central Hospital

Enrolling by invitation
200 enrolled
Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡